Organic Chemistry TRIZ Cases

Specific OLED host material combinations tune energy levels and thermal stability to cut driving voltage while preserving efficiency and lifespan.

Recycling ODH and epoxidation effluent without ethylene-ethane separation cuts cryogenic distillation cost and improves carbon efficiency.

An alanyl-blocked Nile blue probe cuts background interference by shifting fluorescence peaks after APN cleavage, enabling sensitive urine and in vivo detection.

Bis-(organoselanyl urea)aryl compounds inhibit cancer cell growth while minimizing toxicity and side effects versus traditional chemotherapy.

Specific aminoquinolone substitutions improve DGKα inhibition while enhancing T-cell immune response in suppressed tumor microenvironments.

Targeted oxime derivatives suppress TNF-α and IL-6 to protect against hepatitis, fatty liver, and disrupted lipid metabolism.

Synthetic tetrahydropyran derivatives recreate patchouli-like camphoraceous, woody, and earthy notes with better supply stability and practical formulation use.

Azine-triphenylene deuteration strengthens OLED organic layers, improving thermal stability, lowering driving voltage, and extending service life.

Orthogonal linkers enable one-pot bifunctional compound screening, cutting isolation steps while preserving purity and structural diversity.

Flexible intermediates and controlled reaction conditions expand aminopyridazine synthesis routes while improving yield and limiting by-products.

Thermally activated delayed fluorescence compounds minimize singlet-triplet splitting to improve blue OLED efficiency and lifetime.

Small-molecule IL-17A inhibitors enable oral psoriasis treatment, aiming to retain potency while improving convenience and lowering cost.

A triazine-carbazole transport compound improves charge balance, electron mobility, and layer stability to extend OLED lifespan.

Novel quinoline compounds modulate POLRMT to improve mitochondrial transcription control for cancer and metabolic disorders.

A tailored resin composition enables low-temperature curing for high-resolution micro OLED microlenses while keeping high refractive index and visible-light transmittance.

A specific terminal-group fluororesin suppresses heat-melt yellowing in thick molded parts while improving transparency, yield, and molecular weight control.

A fluorinated ether lubricant strengthens thin magnetic media layers by improving adhesion and resisting pickup, spin-off, and corrosion.

N-substituted tetrahydrothienopyridine derivatives are developed to improve antiviral treatment for severe dengue and other Flaviviridae infections.

Electrophilic fluorination of pyrazole at pH 6-8 enables selective 4-fluoro-1H-pyrazole synthesis without hydrazine or corrosive acid conditions.

A staged molten-salt cooler and boosted boiler-water layout recovers process heat as 15.6 MPag steam while limiting dust buildup and tar adhesion.

Tailored amino lipid structures improve nucleic acid targeting, delivery efficiency, and biodegradability in lipid nanoparticles.

Targeted heterocyclic MRGPRX4 modulators improve treatment of pruritus, pain, and autoimmune disorders where existing therapies lack specificity.

Branched amino acid derivatives from lactam ring opening deliver low CMC, strong surface tension reduction, and scalable surfactant synthesis.

Triazine-based compounds tune LUMO, dipole moment, and melting point to improve electron transport layer voltage, efficiency, and lifetime.

Bulky substituents suppress intermolecular aggregation in a blue luminescent compound, improving OLED color purity and luminescence efficiency.

A phenolic compound mixture improves resin processing stability by limiting heat- and oxygen-driven degradation, viscosity rise, and discoloration.

Reactive ketone bio-based methacrylate monomers improve paint film cross-linking, boosting solvent and scrub resistance after drying.

A mutant penicillin acylase enables one-step aqueous amoxicillin synthesis, removing 6-APA isolation while improving yield and process efficiency.

Selective Syk-focused inhibitors curb band 3 phosphorylation to stabilize erythrocyte membranes, reduce microparticles, and limit growth suppression.

Adding 3-hydroxyhispidin or analogs with NAD(P)H enables bioluminescent detection of fungal luciferase in higher fungi.

Targeting GluN2B and sigma-1 receptors helps cut cough frequency and delay onset when standard chronic cough treatments give only temporary relief.

Transdermal and nasal indole formulations bypass first-pass metabolism to stabilize plasma levels and enable safer, more reliable microdosing.

Semisolid amino acid nitrate and nitrite compositions improve solubility and nitric oxide release to achieve faster vasodilation at lower doses.

A palladium-phosphine coupling route raises thienopyrimidine yield, simplifies purification, and cuts waste for industrial production.

A low-energy cleavable tag separates reporter fragmentation from peptide breakup, improving MS quantification accuracy without extra isolation steps.

Selective blue-light absorption compounds filter harmful short wavelengths while preserving light color and more natural visual comfort.

Small-molecule GLP-1R agonists enable oral dosing while resisting DPP4 degradation to treat obesity, NASH, and type 2 diabetes.

A dibenzylamine ring-expansion route replaces hazardous azides, simplifying oxetan-2-ylmethanamine production and lowering safety burden.

Bicyclic inhibitors selectively target the CBX7 chromodomain to block H3K27me3 binding, suppress cancer cell growth, and restore chemotherapy sensitivity.

Covalent multifunctional probes enable specific labeling in mixed cell populations and stable bioluminescent monitoring over longer assays.

Adding sodium carbonate at the tower bottom enables compact DMSO distillation with lower energy use, fewer impurities, and lower cost.

Cellulase hydrolysis replaces purified enzymes and harsh acid steps, enabling scalable colchicine production with safer methylating agents.

A Formula 1 heterocyclic emitter improves electron-hole recombination balance and charge transfer, supporting efficient blue OLED emission and longer life.

Oxone and sodium bicarbonate enable mild mitragynine oxidation with controlled mixing, improving conversion and delivering high-purity 7-hydroxymitragynine.

NAMs targeting the CRFBP-CRF2 complex blunt CRF-driven NMDAR potentiation in VTA dopamine neurons, opening a new AUD treatment route.

An MS-cleavable photo-crosslinker simplifies complex XL-MS products, enabling sensitive identification and broader protein interaction mapping.

A bis-organoselanyl urea scaffold improves cancer cell growth inhibition while limiting toxicity to non-cancer cell lines.

A meso-aryl shielding design protects heptamethine cyanine dyes from aggregation, instability, and poor pharmacokinetics in NIR bioimaging.

Fruit juice rich in malic acid enables solvent-free pyrrole synthesis under mild conditions, reducing hazardous reagents while preserving functional group compatibility.

Fused tricyclic oxalamide compounds improve HBV inhibition while addressing toxicity, off-target activity, solubility, and bioavailability.

Novel cationic lipids enhance nucleic acid encapsulation efficiency while reducing cytotoxicity via structural parameter changes.

A tri(biphenylyl)amine compound enables efficient charge transport in organic electroluminescence devices.

Aminal and enamine precursors derived from hydroxy-decal-enal release fragrance via controlled breakdown.

A polymer material incorporates a specific ultraviolet absorbent compound to maintain high absorption capacity without precipitation or bleeding.

pH-sensitive and oxidation-sensitive metal-free prodrugs deliver targeted carbon monoxide to disease sites while minimizing toxicity to healthy tissues.

Specific fluorine-substituted aromatic sulfonium salts improve micropatterning resolution and curing sensitivity by optimizing molecular structure parameters.

Phenanthroline compounds boost electron mobility and thermal stability in OLEDs by maintaining amorphous morphology and balancing charge transport.

Extracting phthalimide by-products from aqueous reaction mixtures using sequential temperature-controlled solvent steps.

Segmented solvent extraction isolates dihydroxyindoles in organic phases, reducing cyanide contamination while maintaining high yield.

Formula I compounds selectively block Nav1.7 and Nav1.8 channels to relieve pain while avoiding CNS and cardiovascular side effects.

Replacing cyanide-based Strecker synthesis, carbamoyllithium intermediates enable high diastereoselectivity and yield for primary and secondary amides.

Biphasic extraction removes furfural during acid hydrolysis of stillage, preventing degradation and improving yield.

Silane attachment and interstitial polishing stabilize surface chemistry while reducing manufacturing complexity in flow cell packages.

Modified ligand structures improve compound volatility, allowing high-dielectric constant films to form at lower temperatures without sacrificing step coverage.

SPNS2 inhibitors block lymph sphingosine 1-phosphate export, avoiding bradycardia and endothelial dysfunction caused by receptor agonists.

A chromen-2-one monoamine reuptake inhibitor increases clitoral blood flow and temperature to enhance sexual arousal.

Metal salt derivatives of alpha-hydroxy phenylacetic acid increase peak recrystallization temperature while maintaining shrinkage consistency in polyethylene.

Composite lipid nanoparticles protect nucleic acids from degradation while improving cell permeability through optimized formulation parameters.

Synthesized compounds selectively target COX-2, Akt, and ROCK enzymes to overcome limited effectiveness of conventional lung cancer treatments.

Engineered strains suppress fatty acid synthase enzymes to divert malonyl-CoA flux, increasing yield of non-fatty acid chemicals.

Cyclohexyl isoquinolinone compounds bind to MDM2 proteins to block the p53-MDM2 interaction, restoring tumor suppressor activity.

Formula I compounds selectively target Syk kinase pathways, reducing inflammation while minimizing side effects in asthma and rheumatoid arthritis.

ASBT inhibitors block intestinal bile acid recycling to stimulate satiety peptides, reducing food intake and lowering blood glucose levels.

Low recycle ratios and high space velocity extend catalyst life while producing heavy distillates without complex separation steps.

A low SAPS lubricating oil composition uses a high-ratio phenate and sulfonate detergent blend to maintain piston cleanliness.

Metathesized fatty acid polyol esters deliver high solvency with low volatile organic compounds by leveraging local polarity in renewable feedstocks.

Hydroxy-substituted amino derivatives inhibit the PI3K/Akt pathway via allosteric mechanisms to modulate immune mediator release.

Formula I compounds decrease Btk enzymatic activity to treat autoimmune disorders by modulating B-cell and T-cell signaling pathways.

Evaporative crystallization reduces total organic carbon in brine, conserving chlorine gas and hypochlorite for chlor-alkali electrolysis.

A novel triazine derivative acts as a Bruton's tyrosine kinase inhibitor.

A resist composition incorporating a specific resin structural unit improves critical dimension uniformity in microfabrication patterns.

Heterocyclic core structures enable selective or dual inhibition of BCL-2 and BCL-XL proteins to treat associated cancers.

A styryl-based compound enhances pi-conjugation in the emission layer to improve light-emitting efficiency and color purity.

N-pyridinyl epiminocycloheptapyridine derivatives modulate GPR65 receptors to alter immune cell phenotypes in proliferative disorders.

Targeting allosteric sites bypasses ATP-site mutations like T790M, restoring therapeutic efficacy against resistant non-small-cell lung cancer.

Quinuclidine ester analogues act as selective M3 receptor antagonists to produce bronchodilation in the lungs.

Specific bicyclic heterocyclic compounds inhibit PRMT5 enzyme activity to treat diseases linked to its overexpression.

Organic carbon monoxide prodrugs deliver controlled therapeutic gas amounts by replacing toxic metal complexes and complex mechanical delivery systems.

Pyrazolo[1,5-a][1,3,5]triazine derivatives inhibit transcriptional CDKs with high specificity, reducing off-target toxicity compared to flavopiridol.

Polysiloxane surface treatment resolves wetting issues on low-energy substrates, ensuring uniform organic semiconductor deposition and high charge mobility.

Replacing phosphorus catalysts with basic cesium salts eliminates contamination and boosts yield above 90 percent.

MXD6 polyamide compounds with transition metals scavenge oxygen in polymer matrices, reducing haze from immiscibility.

Continuous oxidation of DMTD intermediates with hydrogen peroxide reduces chemical oxygen demand in effluents and improves yield.

Replacing amine catalysts with ionic liquids balances extended working time and fast cure rates without reducing sealant elongation.

Triphenylene benzo-fused thiophene hosts prevent energy quenching by maintaining triplet energy levels above phosphorescent dopants.